Eli Lilly and Company
LLY
$807.04
-$19.68-2.38%
| Weiss Ratings | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Reward Grade | B | |||
| Rating Factors | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Weak | |||
| Growth Index | Good | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Good | |||
| Beta / Standard Deviation | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.48 | |||
| Price History | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 2.39% | |||
| 30-Day Total Return | -9.44% | |||
| 60-Day Total Return | -12.48% | |||
| 90-Day Total Return | -2.76% | |||
| Year to Date Total Return | 37.17% | |||
| 1-Year Total Return | 38.09% | |||
| 2-Year Total Return | 120.54% | |||
| 3-Year Total Return | 239.26% | |||
| 5-Year Total Return | 616.09% | |||
| 52-Week High % Change | -14.99% | |||
| 52-Week Low % Change | 47.19% | |||
| Price | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $972.53 | |||
| 52-Week Low Price | $561.65 | |||
| 52-Week Low Price (Date) | Dec 15, 2023 | |||
| 52-Week High Price (Date) | Aug 22, 2024 | |||
| Valuation | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 744.40B | |||
| Enterprise Value | 771.64B | |||
| Price/Earnings (TTM) | 89.39 | |||
| Earnings Per Share (TTM) | 9.25 | |||
| Earnings Per Share Growth | 67.65% | |||
| Price/Earnings To Growth | 1.32 | |||
| Price/Sales (TTM) | 18.31 | |||
| Price/Book (Q) | 52.24 | |||
| Enterprise Value/Revenue (TTM) | 18.88 | |||
| Price | $807.04 | |||
| Enterprise Value/EBITDA (TTM) | 46.58 | |||
| Enterprise Value/EBIT | 51.80 | |||
| Market Cap Category | Mega Cap | |||
| Dividends and Shares | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 905.00M | |||
| Dividend Yield | 0.63% | |||
| Div. Per Share (Most Recent) | $1.30 | |||
| Dividend Per Share (TTM) | $5.20 | |||
| Payout Ratio (TTM) | 54.12% | |||
| Dividend Per Share (Most Recent) | $1.30 | |||
| Company Info | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 317 276 2000 | |||
| Address | Lilly Corporate Center Indianapolis, IN 46285 | |||
| Website | www.lilly.com | |||
| Country | United States | |||
| Year Founded | 1876 | |||
| Profitability | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 36.45% | |||
| Profit Margin | 20.48% | |||
| Management Effectiveness | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 13.95% | |||
| Return on Equity | 65.32% | |||
| Income Statement | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 40.86B | |||
| Total Revenue (TTM) | 40.86B | |||
| Revenue Per Share | $45.15 | |||
| Gross Profit (TTM) | 33.06B | |||
| EBITDA (TTM) | 16.57B | |||
| EBIT (TTM) | 14.90B | |||
| Net Income (TTM) | 8.37B | |||
| Net Income Avl. to Common (TTM) | 8.37B | |||
| Total Revenue Growth (Q YOY) | 20.43% | |||
| Earnings Growth (Q YOY) | 1,790.42% | |||
| EPS Diluted (TTM) | 9.25 | |||
| EPS Diluted Growth (Q YOY) | 1,777.12% | |||
| Balance Sheet | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 3.52B | |||
| Cash Per Share (Q) | $3.89 | |||
| Total Current Assets (Q) | 31.42B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 14.32B | |||
| Current Ratio (Q) | 1.273 | |||
| Book Value Per Share (Q) | $15.82 | |||
| Total Assets (Q) | 75.61B | |||
| Total Current Liabilities (Q) | 24.67B | |||
| Total Debt (Q) | 31.23B | |||
| Total Liabilities (Q) | 61.29B | |||
| Total Common Equity (Q) | 14.24B | |||
| Cash Flow | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -10.31B | |||
| Cash from Financing (TTM) | 5.00B | |||
| Net Change in Cash (TTM) | 988.20M | |||
| Levered Free Cash Flow (TTM) | -1.65B | |||
| Cash from Operations (TTM) | 6.03B | |||
